$540.84
7.11[1.33%]
At close: Apr 25
$540.84
0[0.00%]
After Hours: 4:00PM EDT
Elevance Health
(NYSE:ELV)Elevance Health Stock (NYSE:ELV), Analyst Ratings, Price Targets, Predictions
Elevance Health Inc has a consensus price target of $548, established from looking at the 50 latest analyst ratings. The last 3 analyst ratings were released from Mizuho, RBC Capital, and UBS on April 24, 2024, April 19, 2024, and April 19, 2024. With an average price target of $588.33 between Mizuho, RBC Capital, and UBS, there's an implied 8.78% upside for Elevance Health Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Mizuho
RBC Capital
UBS
Wells Fargo
Truist Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Elevance Health
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/24/2024 | ELV | Buy Now | Elevance Health | $540.84 | 8.17% | Mizuho | Ann Hynes | $575 → $585 | Maintains | Buy | Get Alert |
| 04/19/2024 | ELV | Buy Now | Elevance Health | $540.84 | 6.32% | RBC Capital | Ben Hendrix | $574 → $575 | Maintains | Outperform | Get Alert |
| 04/19/2024 | ELV | Buy Now | Elevance Health | $540.84 | 11.86% | UBS | A.J. Rice | $585 → $605 | Maintains | Buy | Get Alert |
| 04/19/2024 | ELV | Buy Now | Elevance Health | $540.84 | 10.94% | Wells Fargo | Stephen Baxter | $557 → $600 | Maintains | Overweight | Get Alert |
| 04/19/2024 | ELV | Buy Now | Elevance Health | $540.84 | 10.94% | Truist Securities | David Macdonald | $580 → $600 | Reiterates | Buy → Buy | Get Alert |
| 04/19/2024 | ELV | Buy Now | Elevance Health | $540.84 | 11.68% | Jefferies | David Windley | $602 → $604 | Maintains | Buy | Get Alert |
| 04/19/2024 | ELV | Buy Now | Elevance Health | $540.84 | 14.82% | Barclays | Andrew Mok | $584 → $621 | Maintains | Overweight | Get Alert |
| 04/10/2024 | ELV | Buy Now | Elevance Health | $540.84 | 7.24% | Cantor Fitzgerald | Sarah James | → $580 | Reiterates | Overweight → Overweight | Get Alert |
| 04/08/2024 | ELV | Buy Now | Elevance Health | $540.84 | 2.99% | Wells Fargo | Stephen Baxter | $561 → $557 | Maintains | Overweight | Get Alert |
| 04/04/2024 | ELV | Buy Now | Elevance Health | $540.84 | 7.24% | Cantor Fitzgerald | Sarah James | → $580 | Reiterates | Overweight → Overweight | Get Alert |
| 03/06/2024 | ELV | Buy Now | Elevance Health | $540.84 | 7.98% | Barclays | Andrew Mok | → $584 | Initiates | → Overweight | Get Alert |
| 02/14/2024 | ELV | Buy Now | Elevance Health | $540.84 | 7.24% | Cantor Fitzgerald | Sarah James | $547 → $580 | Maintains | Overweight | Get Alert |
| 02/02/2024 | ELV | Buy Now | Elevance Health | $540.84 | 1.14% | Cantor Fitzgerald | Sarah James | → $547 | Reiterates | Overweight → Overweight | Get Alert |
| 01/25/2024 | ELV | Buy Now | Elevance Health | $540.84 | 1.14% | Cantor Fitzgerald | Sarah James | → $547 | Reiterates | Overweight → Overweight | Get Alert |
| 01/25/2024 | ELV | Buy Now | Elevance Health | $540.84 | 6.13% | RBC Capital | Ben Hendrix | $572 → $574 | Maintains | Outperform | Get Alert |
| 01/19/2024 | ELV | Buy Now | Elevance Health | $540.84 | 1.14% | Cantor Fitzgerald | Sarah James | → $547 | Reiterates | Overweight → Overweight | Get Alert |
| 11/21/2023 | ELV | Buy Now | Elevance Health | $540.84 | 1.14% | Cantor Fitzgerald | Sarah James | → $547 | Reiterates | Overweight → Overweight | Get Alert |
| 11/17/2023 | ELV | Buy Now | Elevance Health | $540.84 | 2.06% | JP Morgan | Lisa Gill | $569 → $552 | Maintains | Overweight | Get Alert |
| 10/19/2023 | ELV | Buy Now | Elevance Health | $540.84 | 1.14% | Cantor Fitzgerald | Sarah James | → $547 | Reiterates | Overweight → Overweight | Get Alert |
FAQ
What is the target price for Elevance Health (ELV)?
The latest price target for Elevance Health (NYSE: ELV) was reported by Mizuho on April 24, 2024. The analyst firm set a price target for $585.00 expecting ELV to rise to within 12 months (a possible 8.17% upside). 30 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Elevance Health (ELV)?
The latest analyst rating for Elevance Health (NYSE: ELV) was provided by Mizuho, and Elevance Health maintained their buy rating.
When was the last upgrade for Elevance Health (ELV)?
The last upgrade for Elevance Health Inc happened on April 27, 2023 when Morgan Stanley raised their price target to $571. Morgan Stanley previously had an equal-weight for Elevance Health Inc.
When was the last downgrade for Elevance Health (ELV)?
The last downgrade for Elevance Health Inc happened on July 12, 2023 when Wolfe Research changed their price target from N/A to N/A for Elevance Health Inc.
When is the next analyst rating going to be posted or updated for Elevance Health (ELV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Elevance Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Elevance Health was filed on April 24, 2024 so you should expect the next rating to be made available sometime around April 24, 2025.
Is the Analyst Rating Elevance Health (ELV) correct?
While ratings are subjective and will change, the latest Elevance Health (ELV) rating was a maintained with a price target of $575.00 to $585.00. The current price Elevance Health (ELV) is trading at is $540.84, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.